GENERAL APPROACH TO AMS

During the mission planning phase, prioritize risk mitigation strategies. While at altitude, continue to reassess for AMS, considering differentials that may mimic AMS. Untreated AMS increases risk of HACE, whether AMS is diagnosed or not. Mild AMS can be treated in place with constant monitoring and re-evaluation. Higher risk AMS should be evacuated to lower altitude with repeat evaluations. Use pharmaceuticals and adjuncts listed above if the operational environment prevents rapid evacuation. More severe disease will require more aggressive therapy. There is an extreme risk to forces if AMS increases and or left untreated. Commanders should consider prophylaxis treatment, acclimatization, and if needed aggressive treatment.